2.12000 EUR
0.12
5.36%
Last update Dec 16, 8:08 AM CET
Main market
Day range
2.12000
2.12000
Previous close
2.24000
Open
2.12000
Access this stock data via API
Subscribe
Perspective Therapeutics Inc.
2.12
0.12
5.36%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 17.3M 14.2M 12.2M 11.0M
Selling general and admin 6.6M 6.6M 6.7M 7.0M
Other operating expenses -178.2K -247.2K -291.6K -199.5K
Operating income -23.8M -20.5M -18.6M -17.8M
Non operating interest income
Income 1.7M 1.8M 2.0M 2.3M
Expense 55.4K 101.4K 109.1K -62.2K
Other income expense 1.2M -20.5M
Pretax income -22.1M -18.8M -15.5M -36.0M
Tax provision -1.8M
Net income -22.1M -18.3M -15.5M -34.2M
Basic EPS -0.4 -0.3 -0.3
Diluted EPS -0.4 -0.3 -0.3
Basic average shares 63.3M 63.3M 61.7M
Diluted average shares 63.3M 63.3M 61.7M
EBITDA -21.4M -18.0M -14.8M -14.9M
Net income from continuing op. -22.1M -18.3M -15.5M -34.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 52 minutes

14:07
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).